Singapore Paincare Holdings Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Singapore Paincare Holdings hat ein Gesamteigenkapital von SGD23.0M und eine Gesamtverschuldung von SGD3.7M, wodurch sich der Verschuldungsgrad auf 16.2% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen SGD40.6M bzw. SGD17.6M. Singapore Paincare Holdings Das EBIT des Unternehmens beträgt SGD2.8M, so dass der Zinsdeckungsgrad 5.6 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von SGD7.2M.

Wichtige Informationen

16.2%

Verhältnis von Schulden zu Eigenkapital

S$3.73m

Verschuldung

Zinsdeckungsgrad	5.6x
Bargeld	S$7.22m
Eigenkapital	S$23.03m
Gesamtverbindlichkeiten	S$17.57m
Gesamtvermögen	S$40.60m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: FRQDie kurzfristigen Aktiva des Unternehmens (SGD12.8M) übersteigen seine kurzfristigen Passiva (SGD9.8M).

Langfristige Verbindlichkeiten: FRQDie kurzfristigen Vermögenswerte des Unternehmens (SGD12.8M) übersteigen seine langfristigen Verbindlichkeiten (SGD7.7M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: FRQ über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: FRQ Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 662.9% auf 16.2% zurückgegangen.

Schuldendeckung: FRQDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (100.1%).

Zinsdeckung: FRQDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (5.6x Coverage) gut gedeckt.

Singapore Paincare Holdings Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Full year 2024 earnings released: EPS: S$0.011 (vs S$0.004 loss in FY 2023)

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 25, 2024

Singapore Paincare Holdings Limited Announces Changes to the Composition of the Board

Full year 2024 earnings released: EPS: S$0.012 (vs S$0.003 loss in FY 2023)

Singapore Paincare Holdings Limited Appoints Isaac Peh Lin Siah as Financial Controller, Effective August 22, 2024

New minor risk - Dividend sustainability

Now 23% undervalued

High number of new directors

Singapore Paincare Holdings Limited Announces the Appointment of Soh Chiong Siong as Financial Controller, Effective April 22, 2024

Insufficient new directors

Now 22% undervalued after recent price drop

Singapore Paincare Holdings Limited Announces Yap Beng Tat, Richard Resigns as Independent Non-Executive Director

Singapore Paincare Holdings Limited Announces Resignation of Lim Mong Ai, Karen as Financial Controller

Now 20% undervalued

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023, Payable on November 17, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 27, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited to Report Fiscal Year 2023 Results on Aug 29, 2023

New minor risk - Financial data availability

Singapore Paincare Holdings Limited Appoints Lim Mong Ai, Karen as Financial Controller, Effective July 1, 2023

First half 2023 earnings released

Singapore Paincare Holdings Limited Appoints Lim Kah Meng as Chairman of the Remuneration Committee and A Member of the Audit Committee and the Nominating Committee

Upcoming dividend of S$0.012 per share

Singapore Paincare Holdings Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 30 June 2022

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Announces Cessation of Chong Weng Hoe as Independent Non-Executive Director, Chairman of Remuneration Committee and Member of the Audit Committee and Nominating Committee

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Recommends Final Dividend

Singapore Paincare Holdings Limited Announces Promotion of Leow Yong Kin from Financial Controller to Chief Financial Officer

High number of new and inexperienced directors

High number of new and inexperienced directors

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Singapore Paincare Holdings Limited Appoints Dr. Lim Kah Meng as Independent Non-Executive Director

First half 2021 earnings released: EPS S$0.004 (vs S$0.01 in 1H 2020)

Singapore Paincare Holdings Limited (Catalist:FRQ) completed the acquisition of 40% stake in KCS Anaesthesia Services Pte. Ltd from Kong Chee Sang.

New 90-day high: S$0.23

Singapore Paincare Holdings Limited (Catalist:FRQ) agreed to acquire 40% stake in Kong Chee Seng fro SGD 2.4 million.

Singapore Paincare Holdings Limited has completed a Follow-on Equity Offering in the amount of SGD 3.96 million.

Full year earnings released - EPS S$0.031

Singapore Paincare Holdings Limited (Catalist:FRQ) entered into agreement to acquire AE Medical Sengkang Private Limited from Wong Shing Yip for SGD 0.17 million.

Singapore Paincare Holdings Limited has completed an IPO in the amount of SGD 5.33412 million.

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen